📋🔬 International Projects - IIS Aragón (February 2024)
February 2024
 
The international projects office of the IIS Aragón has created this monthly newsletter through which it will inform about the calls for projects that are open, the events and the conferences that may be interesting in this regard for the research and management staff. 

If you want to contact the international projects office you can do so through this email address: international@iisaragon.es.
Open calls


FEB
2024
EUROPE HORIZON – CLUSTER 2
 
First stage
FEB

2024

Second stage
SEP

2024
EUROPE HORIZON – CLUSTER 2
  • HORIZON-CL4-2024-RESILIENCE-01-36: Advanced biomaterials for the Health Care (AI)

    Strategic Innovation Markets driven by Advanced Materials presents synergies with the energy-intensive and manufacturing industries, in view of both the circularity approaches and low-carbon technologies; and with Cluster 1 'Health', in view of areas on bio-based materials.

FEB
2024
HORIZON EUROPE – MSCA COFUND 2023

Call for proposal MSCA COFUND (HORIZON-MSCA-2023-COFUND-01-01) co-finances new or existing doctoral programs and postdoctoral fellowship schemes with the aim of spreading the best practices of the MSCA including international, inter-sectoral and interdisciplinary research training, as well as international and cross-sectoral mobility of researchers at all stages of their career.
In practice, MSCA COFUND provides complementary funding for doctoral or postdoctoral programs managed by entities established in EU Member States or Horizon Europe Associated Countries. Those co-funded programs must follow MSCA's good practice in terms of international recruitment and minimum standard of employment for the recruited fellows as described in the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers.
letter of intent

FEB

2024

Deadline
APR

2024
FRIEDREICH'S ATAXIA RESEARCH ALLIANCE

FARA supports research through funding competitive grants across the spectrum from basic research through drug development and clinical research programs in Friedreich's Ataxia (FA). We promote collaboration among scientists, advocate for public-private partnerships and host open forums for leading scientists to share their insights and ideas to advance therapeutic development for FA.
FARA's Grant types, Deadlines, and Budget Limits are described in the table below. You can view special interest requests for proposals (RFPs) and other grant program updates and announcements here.
All investigators interested in FA-related research are invited to submit a Letter of Intent (LOI) through our submission portal. All proposed research must fall within FARA's Grant Program Priorities.
For more information on how to apply for a FARA grant, click here.
letter of intent

FEB

2024

Full proposal
APR

2024
FOUNDATION FOR RESEARCH IN RHEUMATOLOGY – FOREUM

FOREUM CAREER RESEARCH GRANTS 2024: Through this call, the aim is to promote the emergence of new research leaders in the field of rheumatology and musculoskeletal diseases. To this end, the development, for three years, of innovative research projects (clinical or basic) in this field carried out by young researchers with an excellent scientific record will be financed.

FEB
2024
EUROPE HORIZON – CLUSTER 6

FEB
2024
HORIZON EUROPE – MSCA STAFF EXCHANGES 2023

Call for proposal MSCA Staff Exchange (HORIZON-MSCA-2023-SE-01-01) promote innovative international, inter-sectoral and interdisciplinary collaboration in research and innovation through exchanging staff and sharing knowledge and ideas at all stages of the innovation chain. The scheme fosters a shared culture of research and innovation that welcomes and rewards creativity and entrepreneurship and helps turn ideas into innovative products, services or processes. It is open to research, technical, administrative and managerial staff supporting R&I activities.
 

FEB
2024
EUROPE HORIZON – CLUSTER 6
 
  • HORIZON-CL6-2024-GOVERNANCE-01-3: The role of mainstream media, social media and marketing in fostering healthy and sustainable consumption patterns and how to encourage good practices.

TUE
2024
CANCER RESEARCH INSTITUTE – CRI
CRI IRVINGTON POSTDOCTORAL FELLOWSHIPS 2024-1: Through this call we aim to support young scientists from universities and research centers around the world, in their training in the field of basic immunology and cancer immunology. For this, your contract will be financed for 3 years + additional aid for research expenses, travel, diets, medical insurance, among others, associated with a research project directly related to the study of the role of the immune system in cancer.
 

TUE
2024


 

 
 
JPND 2024 CALL
 
MECHANISMS AND MEASUREMENT OF DISEASE PROGRESSION IN THE INITIAL PHASE OF NEURODEGENERATIVE DISEASES

- Aim: Improve understanding of disease mechanisms and advance the measurability of disease progression in the early and presymptomatic phases of neurodegenerative diseases.
- Mandatory of 1 Spanish partner in the proposal with the role of coordinator 
Beneficiary entities: Public research/monographic centers on neurodegenerative diseases.
- Funding organization: Carlos III Health Institute

Learn more
 
Pre-proposals

TUE
2024

Full proposals

SEP
2024

 
 
EP PERMED – JOINT TRANSNATIONAL CALL (JTC) 2024
PMTARGETS: Identification or validation of targets for personalized medicine approaches.

Objectives of the call:
  • Identify or validate targets in combination with the analysis of biomarkers that allow monitoring treatment and stratifying patients.
  • Promote interdisciplinary collaboration between preclinical and clinical, multidisciplinary and intersectoral research, to enhance the application of personalized medicine.
Funding organization: Carlos III Health Institute

Learn more

MAR 2024
  • Supports the early-stage development of radically new technologies, with the potential to create new markets and/or address global challenges, based on innovative high-risk, high-benefit research from science to technology (TRLs 1 to 4). 

MAR 2024
ISIDORE – CALLS FOR PROPOSALS
 
  • RISK GROUP 4 PATHOGENS: Risk Group 4 (RG4) pathogens usually cause serious human or animal disease and can be readily transmitted from one individual to another, directly or indirectly. Effective treatment and preventive measures are not usually available.
    The ISIDORe consortium supports scientists with an interest in these pathogens with high individual and community risk.
    Researchers are invited to submit any proposal that:
    - Can be advanced by access to at least one of our services,
    - Falls under one of the following sections (see SCOPE), and
    - Is focused on at least one eligible RG4 pathogen (see below and full ISIDORe PPP list).
 
Pre-proposals

TUE
2024

Full proposals

SEP
2024

 
 
ERA-NET NEURON JTC 2024 “RECIPROCAL INTERACTION BETWEEN THE BRAIN AND THE BODY”
 
Objective of the transnational ERA NET NEURON initiative:
Facilitate multinational, collaborative research projects that address critical clinical and translational questions to improve our knowledge of the role of reciprocal interactions between the central nervous system and the body in the genesis and progression of neurological and psychiatric diseases.
-   Prevent and treat: A better understanding of these interactions has the potential to discover solutions for the prevention and treatment of these disorders.

Funding organizations: State Research Agency and Carlos III Health Institute.


Learn more

MAR 2024
HORIZON EUROPE - INFRADEV
 

MAR 2024
HORIZON EUROPE - INFRATECH
 

MAR 2024
HORIZON EUROPE – ENHANCING THE EUROPEAN R&I SYSTEM 
 


TUE
2024


 
HORIZON EUROPE – ERC PROOF OF CONCEPT
 
  • ERC-2024-POC: The ERC Proof of Concept Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to Principal Investigators whose proposals draw substantially on their ERC funded research.
    The financial contribution will be awarded as a lump sum of EUR 150.000 for a period of XIX months. The ERC expects that normally proof of concept activities should be completed within 12 months. However, to allow for those projects that require more preparation time, the grant agreements will be signed for 18 months. Extensions of the duration of proof of concept projects may be granted only exceptionally.
Pre-proposals

TUE
2024

Full proposals


JUL
2024
JOINT PROGRAMMING INITIATIVE ON ANTIMICROBIAL RESISTANCE (JPIAMR)
 
Call framed in the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR – Joint Programming Initiative on Antimicrobial Resistance), which aims to coordinate the efforts carried out, from the different associated countries, in the field of antimicrobial resistance.
The call will be co-financed by the European Commission and different financing agencies of the participating countries or regions. In the case of Spain, Instituto de Salud Carlos III will be the financier of the Spanish groups participating in the projects.
Specifically, the call will finance transnational research projects for the development of strategies, tools, technologies and innovative methods for the diagnosis and surveillance of antimicrobial resistance.

Projects must focus on one of the following topics:
1. Develop novel diagnostics, or improve existing ones, that can rule out the use of antimicrobials or help identify the most effective antimicrobial treatment.
2. Develop or improve existing strategies, technologies or methods, or data use strategies to support antimicrobial resistance surveillance in One Health.

More Information

TUE
2024
EUROPE HORIZON – CLUSTER 4
 

TUE
2024
CERV-LS CERV Lump Sum Grants
 
  • CERV-2024-CHILD: Rights of the child and children's participation.
    This call for proposals aims at supporting, advancing and implementing comprehensive policies to protect and promote the rights of the child, including the right to participate. It responds to children's current needs and challenges in the EU, through four priorities, one of them children's mental health.
First stage

APR
2024

Second stage


SEP
2024
HORIZON EUROPE – JU EDCTP3 two stage

APR
2024
HORIZON EUROPE – HEALTH
 
  • HORIZON-HLTH-2024-IND-06-08: Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs).
  • HORIZON-HLTH-2024-IND-06-09: Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators.
  • HORIZON-HLTH-2024-DISEASE-08-12: Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness.
  • HORIZON-HLTH-2024-DISEASE-08-20: Pandemic preparedness and response: Host-pathogens interactions of infectious diseases with epidemic potential.
  • HORIZON-HLTH-2024-TOOL-11-02: Bio-printing of living cells for regenerative medicine.
First stage

APR
2024

Second stage


OCT
2024
HORIZON EUROPE – INNOVATIVE HEALTH INITIATIVE CALL 6
 
  • HORIZON-THU-IHI-2024-06-01:  Support healthcare system resilience through a focus on a persistence in the treatment of chronic diseases.
  • HORIZON-THU-IHI-2024-06-02: Development of evidence based practical guidance for sponsors of the use of real-world-data / real-world evidence.
 

MAY
2024


 
HORIZON EUROPE – JU INNOVATIVE HEALTH INITIATIVE CALL 7
 
 
First stage

MAY
2024

Second stage


OCT
2024
 
INDUSAC
 
The project INDUSAC, funded by Horizon Europe, offers support for short (4-8 weeks) research collaborations between students, researchers and companies. Its objective is to address business challenges through work teams, highlighting female inclusion (at least 50%) and the participation of countries with fewer research opportunities (60%). The call has three deadlines to send Motivation Letters. It is suggested to submit a single solid and detailed letter to maximize your chances.
Events
Global Health EDCTP3 – 2024 
February 6, 2024 | info day

The event provided potential applicants with information on Work Program 2024.
On 06 February 2024 Global Health EDCTP3 will host an online information session (Info day). The event aims to provide potential applicants with information on the Global Health EDCTP3 calls for proposals under Work Program 2024, as well as information on eligibility criteria and other relevant administrative matters.
The different funding opportunities under the 2024 Work Program will be presented and this will be followed by a Questions and Answers (Q&A) session with the online audience. The Info day will take place online (on YouTube) from 11:00 - 13:00 Central European Time (CET). Questions will be received via the Q&A and polling platform, Slido. The links will be provided closer to the date.African and European researchers and innovators as well as citizens and all interested stakeholders are invited to take part in the Info Day.


Lump Sum Funding in Horizon Europe: How does it work? How to write a proposal?
February 8, 2024 | Learn more

The European Commission is organizing a new information day on lump sum financing in Horizon Europe, which will take place on 8 February 2024 and will be broadcast live on the Internet.
During the day, it will be explained how this form of financing works and what should be taken into account when writing a proposal in this case. In addition, there will be a session on practical experiences and a space reserved for questions.
Information about the event is available on the European Commission website.
More information on lump sum financing is available on the "Funding & Tender opportunities" portal. section dedicated to this topic.


Research perspectives on the health impacts of climate change
February 19, 2024 | Pre-registration

This high-level conference will bring together researchers, policymakers and relevant stakeholders to reflect on the research needs in the field of climate change and human health.
Climate change is a global existential challenge that has introduced unprecedented pressures on the planet which are already translating into significant consequences for human health.
Research and innovation (R&I) are key in delivering evidence and tools to understand, prevent and reduce the health impacts of these rapidly unfolding threats. However, there are numerous knowledge gaps that need to be filled and innovation opportunities that remain untapped.
There is also growing momentum and interest at the global level to increase coordination towards a forward-looking research agenda in climate change and health that will be capable of delivering robust evidence for the necessary adaptation and mitigation actions and policies.


ERC Proof of Concept Grant 2024
February 20, 2024


On Tuesday, February 20, 2024, from 13:00 p.m. to 15:00 p.m., the European Office of the FECYT organizes a webinar on the ERC-Proof of concept-2024 call in which you will participate Line Volkers, POC call coordinator of the ERCEA and two success stories of the latest calls resolved, with the following agenda:

Agenda Webinar ERC-Proof of Concept-2024.
• 13.00:13 p.m.-05:XNUMX p.m. Welcome. CKD NCP
• 13:05 p.m. – 13:45 p.m. ERC-Proof of Concept-2024 call. Novelties. Line Volkers. POC call coordinator. ERCEA.
• 13:45 p.m. – 14:00 p.m. The experience of a POC Grantee_ social innovation.

Natalia Fabra. NextENERGY. Simulating the effects of low-carbon investments in electricity markets. University Carlos III of Madrid 

• 14:00 p.m.-14:15 p.m. The experience of a POC Grantee_technological innovation

José Manuel García Aznar. VASTO VAScularized Tumor Organoids on a chip with human placenta vessels as a preclinical model for anticancer therapies. Zaragoza's University. 

• 14:15 p.m.-15:00 p.m. Q&A

 

European Research and Innovation Days (R&I Days) 2024
March 20-21, 2024


The European Commission's annual flagship research and innovation event brings together policymakers, researchers, entrepreneurs, and the public to debate and shape the future of research and innovation in Europe and beyond.
This fifth edition of the event will take place on 20 and 21 March 2024 both physically in Brussels and online, allowing everyone to get involved from anywhere.
The R&I Days 2024 will give you the opportunity to debate how we can make Europe more sustainable and competitive and will celebrate the outcomes and achievements in research and innovation since the launch of the first R&I Framework Program over 40 years ago.
It's your chance to discover successful EU-funded research and innovation projects, experience their impact on our society and debate the importance of continued investment in research and innovation. You can find out more on Horizon Europe, including the Strategic Plan 2025 – 2027 and its Widening Instrument; R&I support to Green and Digital transition; its Global Approach; and many other topics. 
Join us to discuss and shape the future of research and innovation.
More information about the programme, the sessions and the speakers will be available soon. Stay tuned for more news by following us on Twitter @EUScienceInnov and join the conversation on #RiDaysEU.

 


Contact
Aragón Health Research Institute (IIS Aragón)
Biomedical Research Center of Aragon (CIBA)
Avda. San Juan Bosco, nº 13. 50009 - Zaragoza
Tel. +34 976 71 64 17 | +34 976 71 44 02

You receive this newsletter because you are a member of IIS Aragón or because you are interested in its activities. If you do not wish to receive it, please contact international@iisaragon.es to process the unsubscription.


Free stock photos from www.pexels.com